Bafna Pharmaceuticals Limited, a active public limited company, was established on 28 March 1995 in Madras 600 001, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24294TN1995PLC030698. Registered under ROC Roc Chennai. it is listed on BSE: 532989 and NSE: BAFNAPH. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹23.66 Cr.
It upholds a compliant status. In 2024, it reported revenue of ₹155.99 Cr and a net worth of ₹80.84 Cr. Employing 381 professional, Its leadership includes Shanmugam Hemalatha (Whole-Time Director), Upendar Mekala Reddy (Director), Akila Chandrashekar Raju (Director). Past directors included Venkataraman Rajamani, Shanmugam Hemalatha, Nirav Vikram Maniar. It holds ₹68.85 Cr open charges and ₹169.66 Cr settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at 299, Thambu Chetty Streetmadras 600 001 Madras 600 001, Madras 600 001, Tamil Nadu, 600001.
L24294TN1995PLC030698
030698
28 March 1995
₹40.00 Cr
₹23.66 Cr
Roc Chennai
Listed (BSE: 532989, NSE: BAFNAPH)
Active
Explore comprehensive insights into Bafna Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shanmugam Hemalatha | Whole-Time Director | 10 Sep 2020 | Current |
| Upendar Mekala Reddy | Director | 26 Jun 2023 | Current |
| Akila Chandrashekar Raju | Director | 10 Sep 2020 | Current |
| Ravichandran Chitra | Director | 12 Nov 2020 | Current |
| Vinayak Dinesh Dendukuri | Whole-Time Director | 26 Jun 2023 | Current |
| Navin Kumar | Additional Director | 23 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jun 2020 | Past |
| Pramod Abcsdd | Whole-Time Director | 13 Aug 2021 | Past |
| Pramod Abcsdd | Additional Director | 28 May 2018 | Past |
| Pramod Abcsdd | Company Secretary | 11 Aug 2022 | Past |
| Pramod Abcsdd | Director | 10 Sep 2020 | Past |
| Pramod Abcsdd | Director | 20 May 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bafna Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 31.5% increase. The company also saw a substantial fall in profitability, with a 35.19% decrease in profit. The company's net worth Soared by an impressive increase of 10.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Bafna Pharmaceuticals had a promoter holding of 88.29% and a public holding of 11.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹688,510,000.00
₹1,696,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jun 2025 | Others | ₹11.50 Cr | Open |
| 11 Sep 2024 | Others | ₹6.35 Cr | Open |
| 21 Feb 2024 | Others | ₹12.00 Cr | Open |
| 30 Nov 2023 | Others | ₹12.00 Cr | Open |
| 05 Jun 2023 | Others | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Bafna Pharmaceuticals has a workforce of 381 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bafna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bafna Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Palamadai Krishnan Sundaresan was appointed as a Director was appointed as a Director on 19 Sep 2025 & has been associated with this company since 2 months 15 days . was documented.
The activity A charge registered on 23 May 2025 via Charge ID 101124057 with Others was fully satisfied on 04 Sep 2025. was completed.
Navin Kumar was appointed as a Additional Director was appointed as a Additional Director on 23 Jun 2025 & has been associated with this company since 5 months 11 days . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 11.50 Cr with Charge ID 101111395 was registered on 13 Jun 2025. was completed.
Progress on A charge with Others of Rs. 20.00 Cr registered on 27 Oct 2021 with Charge ID 100502255 was modified on 13 Jun 2025. was documented.
Progress on A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101124057 was registered on 23 May 2025. was documented.
The Board of Directors in their meeting held on November 10, 2017 has appointed Ms. Nirmala L, as the Company Secretary and Compliance Officer of the Company with effect from October 23, 2017..
The CIN of Bafna Pharmaceuticals Limited is L24294TN1995PLC030698.
Bafna Pharmaceuticals Limited is headquartered at 299, Thambu Chetty Streetmadras 600 001 Madras 600 001, Madras 600 001, Tamil Nadu, 600001.
Bafna Pharmaceuticals Limited was incorporated on 28 March 1995.
The current directors of Bafna Pharmaceuticals Limited are
The primary industry of Bafna Pharmaceuticals Limited is Manufacturing.
Bafna Pharmaceuticals Limited is listed. It is listed on BSE: 532989 and NSE: BAFNAPH.
The authorized capital of Bafna Pharmaceuticals Limited is ₹40.00 Cr, and the paid-up capital is ₹23.66 Cr.
The compliance status of Bafna Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX